Virtual reality goggles could be a cheaper way to treat vertigo

NCT ID NCT03838562

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using a virtual reality headset is as good as standard equipment for improving balance in people with vertigo. 76 adults with vestibular disorders completed a 3-4 week rehabilitation program. The goal was to see if the cheaper, smaller VR device could match the effectiveness of traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality headset
What this could lead to
If it works, this could offer a more affordable and compact tool for balance rehabilitation in people with vertigo.
What could go wrong
This is a small, early-stage trial (76 people) testing non-inferiority, not superiority. The results may not apply to all types of vertigo, and virtual reality may cause side effects like nausea or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

76 people

The number who actually took part.

Started

Apr 2019

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Symptomatology related to a vestibular disorder, eligible for a rehabilitation program Possible standing position * Informed subject and having signed the informed consent form * Major subject * Affiliation to a social security scheme Exclusion Criteria: * Badly sighted or blind subject (sharpness \<1 / 10th) * Absence of vision of the reliefs * Strabismus important * History of epilepsy * General state strongly altered * Pregnant subject * Major protected by law * Subject deprived of liberty

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Optokinetic stimulation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Paul Coste Floret/ Pavillon Jeanne d'Arc/ Leroy

    Lamalou-les-Bains, France